ADELA AYALA: Open Payments
NPI 1235116138 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,732 in 24 payments from 19 companies in 2025. Trend: 2023 $2,376 · 2024 $2,213 · 2025 $2,732
Food & beverage: $2,732
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $370 |
| Alnylam Pharmaceuticals Inc. | 2 | $283 |
| ABBVIE INC. | 2 | $250 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Fresenius USA Marketing, Inc. | 2 | $144 |
| Biosense Webster, Inc. | 1 | $141 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
Products named: ONPATTRO, IBSRELA, REZDIFFRA, VELPHORO, NUVISION ICE CATHETER, ZORYVE, Leqembi, Korlym.
Industry payments across CA — which companies pay providers there.
